These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 29746911)
1. N-demethylation of N-methyl-4-aminoantipyrine, the main metabolite of metamizole. Bachmann F; Duthaler U; Rudin D; Krähenbühl S; Haschke M Eur J Pharm Sci; 2018 Jul; 120():172-180. PubMed ID: 29746911 [TBL] [Abstract][Full Text] [Related]
2. Non-immunological toxicological mechanisms of metamizole-associated neutropenia in HL60 cells. Rudin D; Lanzilotto A; Bachmann F; Housecroft CE; Constable EC; Drewe J; Haschke M; Krähenbühl S Biochem Pharmacol; 2019 May; 163():345-356. PubMed ID: 30653950 [TBL] [Abstract][Full Text] [Related]
3. Cytochrome P450 1A2 is the most important enzyme for hepatic metabolism of the metamizole metabolite 4-methylaminoantipyrine. Bachmann F; Meyer Zu Schwabedissen HE; Duthaler U; Krähenbühl S Br J Clin Pharmacol; 2022 Feb; 88(4):1885-1896. PubMed ID: 34648192 [TBL] [Abstract][Full Text] [Related]
4. Toxicity of metamizole on differentiating HL60 cells and human neutrophil granulocytes. Rudin D; Roos NJ; Duthaler U; Krähenbühl S Toxicology; 2019 Oct; 426():152254. PubMed ID: 31356851 [TBL] [Abstract][Full Text] [Related]
5. Metamizole is a Moderate Cytochrome P450 Inducer Via the Constitutive Androstane Receptor and a Weak Inhibitor of CYP1A2. Bachmann F; Duthaler U; Meyer Zu Schwabedissen HE; Puchkov M; Huwyler J; Haschke M; Krähenbühl S Clin Pharmacol Ther; 2021 Jun; 109(6):1505-1516. PubMed ID: 33336382 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of cytochrome P450 enzymes involved in ketamine metabolism by use of liver microsomes and specific cytochrome P450 enzymes from horses, dogs, and humans. Mössner LD; Schmitz A; Theurillat R; Thormann W; Mevissen M Am J Vet Res; 2011 Nov; 72(11):1505-13. PubMed ID: 22023129 [TBL] [Abstract][Full Text] [Related]
7. Involvement of cytochrome P450 3A4 enzyme in the N-demethylation of methadone in human liver microsomes. Iribarne C; Berthou F; Baird S; Dréano Y; Picart D; Bail JP; Beaune P; Ménez JF Chem Res Toxicol; 1996 Mar; 9(2):365-73. PubMed ID: 8839037 [TBL] [Abstract][Full Text] [Related]
8. Lack of interaction between zidovudine and 4-methyl-amino-antipyrine, the active metabolite of metamizole, in human liver in vitro. Bacracheva N; Kamali F Methods Find Exp Clin Pharmacol; 1995 Jun; 17(5):299-301. PubMed ID: 8830197 [TBL] [Abstract][Full Text] [Related]
9. The cytochrome P450-catalyzed metabolism of levomepromazine: a phenothiazine neuroleptic with a wide spectrum of clinical application. Wójcikowski J; Basińska A; Daniel WA Biochem Pharmacol; 2014 Jul; 90(2):188-95. PubMed ID: 24841887 [TBL] [Abstract][Full Text] [Related]
10. Assessment of a dry extract from milk thistle (Silybum marianum) for interference with human liver cytochrome-P450 activities. Doehmer J; Weiss G; McGregor GP; Appel K Toxicol In Vitro; 2011 Feb; 25(1):21-7. PubMed ID: 20828605 [TBL] [Abstract][Full Text] [Related]
11. Direct comparison of UDP-glucuronosyltransferase and cytochrome P450 activities in human liver microsomes, plated and suspended primary human hepatocytes from five liver donors. den Braver-Sewradj SP; den Braver MW; Baze A; Decorde J; Fonsi M; Bachellier P; Vermeulen NPE; Commandeur JNM; Richert L; Vos JC Eur J Pharm Sci; 2017 Nov; 109():96-110. PubMed ID: 28778465 [TBL] [Abstract][Full Text] [Related]
12. Cytochrome P450 2C9 catalyzes indomethacin O-demethylation in human liver microsomes. Nakajima M; Inoue T; Shimada N; Tokudome S; Yamamoto T; Kuroiwa Y Drug Metab Dispos; 1998 Mar; 26(3):261-6. PubMed ID: 9492390 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic profiles of the two major active metabolites of metamizole, 4-methylaminoantipyrine (MAA) and 4-aminoantipyrine (AA), after intravenous injection in cats. de Paula VV; Araújo-Silva G; Fernandes NS; Mouta AN; Nunes TL; de Paiva ALC; de Macêdo LB; Arcoverde KN; Urizar JTP Res Vet Sci; 2023 Feb; 155():156-160. PubMed ID: 36701839 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic properties of metamizole active metabolites in Northeastern Brazilian donkeys (Equus asinus). de Macêdo LB; Mouta AN; Araújo-Silva G; Urizar JTP; de Paula VV J Vet Pharmacol Ther; 2021 Sep; 44(5):842-849. PubMed ID: 34268764 [TBL] [Abstract][Full Text] [Related]
15. In vitro metabolism study of buprenorphine: evidence for new metabolic pathways. Picard N; Cresteil T; Djebli N; Marquet P Drug Metab Dispos; 2005 May; 33(5):689-95. PubMed ID: 15743975 [TBL] [Abstract][Full Text] [Related]
16. The involvement of cytochrome P450 3A4 in the N-demethylation of L-alpha-acetylmethadol (LAAM), norLAAM, and methadone. Moody DE; Alburges ME; Parker RJ; Collins JM; Strong JM Drug Metab Dispos; 1997 Dec; 25(12):1347-53. PubMed ID: 9394023 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of In Vitro Cytochrome P450 Inhibition and In Vitro Fate of Structurally Diverse N-Oxide Metabolites: Case Studies with Clozapine, Levofloxacin, Roflumilast, Voriconazole and Zopiclone. Giri P; Naidu S; Patel N; Patel H; Srinivas NR Eur J Drug Metab Pharmacokinet; 2017 Aug; 42(4):677-688. PubMed ID: 27853934 [TBL] [Abstract][Full Text] [Related]
18. Involvement of CYP2B6 in n-demethylation of ketamine in human liver microsomes. Yanagihara Y; Kariya S; Ohtani M; Uchino K; Aoyama T; Yamamura Y; Iga T Drug Metab Dispos; 2001 Jun; 29(6):887-90. PubMed ID: 11353758 [TBL] [Abstract][Full Text] [Related]
19. The metabolism of the piperazine-type phenothiazine neuroleptic perazine by the human cytochrome P-450 isoenzymes. Wójcikowski J; Pichard-Garcia L; Maurel P; Daniel WA Eur Neuropsychopharmacol; 2004 May; 14(3):199-208. PubMed ID: 15056479 [TBL] [Abstract][Full Text] [Related]
20. Reappraisal of human CYP isoforms involved in imipramine N-demethylation and 2-hydroxylation: a study using microsomes obtained from putative extensive and poor metabolizers of S-mephenytoin and eleven recombinant human CYPs. Koyama E; Chiba K; Tani M; Ishizaki T J Pharmacol Exp Ther; 1997 Jun; 281(3):1199-210. PubMed ID: 9190854 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]